Personal Cfo Solutions, LLC Infla Rx N.V. Transaction History

Personal Cfo Solutions, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 18, 2021	SELL	$2.25 - $3.03 $24,750 - $33,330	-11,000 Closed	0 $0
Q2 2021 Jul 22, 2021	SELL	$2.72 - $4.04 $5,440 - $8,080	-2,000 Reduced 15.38%	11,000 $33,000
Q1 2021 Apr 21, 2021	SELL	$3.62 - $6.34 $10,454 - $18,309	-2,888 Reduced 18.18%	13,000 $51,000
Q4 2020 Feb 09, 2021	SELL	$3.82 - $5.32 $3,820 - $5,320	-1,000 Reduced 5.92%	15,888 $79,000
Q3 2020 Nov 02, 2020	BUY	$3.7 - $5.47 $3,700 - $5,470	1,000 Added 6.29%	16,888 $0

Q2 2020 Aug 03, 2020	BUY	$4.59 - $8.96 $72,925 - $142,356	15,888 New	15,888 $73,000

13.8M

12.9K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $72.5M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Personal Cfo Solutions, LLC with notifications on news.